Skip to content

Clinical trials

Inflammation trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Country / region: United States Clear all

1,168 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20017
200212
200313
200423
200528
200649
200743
200835
200947
201047
201154
201260
201349
201443
201546
201654
201746
201861
201955
202045
202158
202267
202354
202442
202551
202641

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed772
Recruiting129
Terminated110
Active, not recruiting50
Unknown status48
Withdrawn30
Not yet recruiting15
Enrolling by invitation11
Suspended3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Emory University27
University of Florida23
Massachusetts General Hospital21
University of California, Los Angeles21
Appalachian State University19
National Institute of Allergy and Infectious Diseases (NIAID)19
VA Office of Research and Development18
Stanford University16
University of California, Davis16
University of California, San Francisco15

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation1,168
Obesity96
Insulin Resistance73
Cardiovascular Diseases70
Pain48
Metabolic Syndrome47
Atherosclerosis39
Diabetes Mellitus34
Infections34
Hypertension31

Trials

Showing 76 to 100 of 1,168. Each trial links to its page on Pharma Observatory.

1,068 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.